News Releases
The latest company news, press releases, and resources about Servier and everything our company has to offer.
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
05.21.2026Servier Presentations at ASCO 2026 Spotlight Expanding Rare Oncology Portfolio-
05.12.2026Emiltatug Ledadotin (Emi-Le) Granted Breakthrough Therapy Designation by the U.S. FDA for Adenoid Cystic Carcinoma (ACC)
-
05.08.2026Day One and Servier Complete Enrollment in Pivotal Phase 3 FIREFLY-2 Trial of Tovorafenib as a Front-Line Treatment for Pediatric Low-Grade Glioma (pLGG)
-
04.23.2026Servier completes the acquisition of Day One Biopharmaceuticals
-
03.06.2026Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio
Media Contacts
Servier Media Relations
USmediarelations@servier.com